While three decades ago it was rare for a child or teen to be diagnosed with type 2 diabetes, today, the American Medical Association (AMA) estimates that there are about 3,700 new cases a year among youth in the United States. While the majority of new diabetes diagnoses in children are still type 1 – … Continue reading Type 2 Diabetes in Youth: How Serious Is It?
Diabetic peripheral neuropathy is caused by reduced blood flow to the extremities. High blood glucose levels damage blood vessels and affect the blood flow. Those with type 2 diabetes are at a higher risk for foot ulcers and lower limb amputations. They also account for 60 percent of the limb amputations, according to the American … Continue reading Study Shows Therapeutic Footwear Can Help Prevent Foot Ulcers
You’re at your destination and ready to see what there is to see. The real question is this: Are you ready to walk? For people with diabetes, this can be a complicated question. Those who’ve dealt with the disease for many years may have some sort of problem with their feet. It doesn’t have to … Continue reading Keeping Your Feet Fit for Travel
One of the most debilitating risks of diabetes is peripheral neuropathy, which can impact millions of people each year and often leads to amputation. It’s difficult to treat, but researchers at Boston Children’s Hospital are working to develop a skin cream that may relieve it. The cream, which has been tested on mice in two … Continue reading Skin Cream Could Treat Peripheral Neuropathy
Physicians may be able to predict if diabetic patients will develop peripheral neuropathy, thanks to results of new research. According to the research, which appeared in the American Diabetes Association journal Diabetes Care, the levels of an enzyme known as neuron-specific enolase are elevated in people with diabetes, even more so in those suffering from … Continue reading Enzyme Discovery Could Predict Diabetic Neuropathy
The US Food and Drug Administration has approved US sales of NUCYNTA® ER (tapentadol), a twice-daily extended-release oral analgesic for the treatment of pain from diabetic peripheral neuropathy. The drug, produced by New Jersey-based Janssen Pharmaceuticals, Inc., provides around-the-clock management for moderate to severe chronic neuropathic pain. Janssen says that it is currently the only … Continue reading FDA Approves New Neuropathy Pain Drug
One quarter of patients with diabetic neuropathy undergo unnecessary, expensive tests, according to a study by Brian Callaghan, MD, of the University of Michigan Medical School. When Dr. Callaghan and his team looked at 1996-2007 Medicare claims of patients diagnosed with peripheral neuropathy, they found that the most common test performed was an MRI of … Continue reading Unnecessary, Expensive Tests Performed for Diabetic Neuropathy